• Christopher Hall

Health Care shares up +30 to +700%


This week there's a common theme of cancer treatment and getting exposure to the the lucrative US patient, healthcare system. Starting with Novita Health (NHL), formerly Avexa, up almost 800% over the fortnight. Novita is the World first gaming system designed to assist children with developmental disabilities such as autism and down syndrome and ADHD. NHL Announced the technology will be delivered via the US Reimbursement Code system and start working with Duke University with ~2,000 children. Imugene (IMU), the company that focuses on gastric and breast cancer vaccines is up 65%. IMU work on clinical stage immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Strong moves after investor conference call that followed the AGM Oncosil Medical (OSL) are up +30.4% for the last two weeks. OSL are the medical device company working to advance radiation for cancer patients, specifically liver and pancreatic cancer. Working on CE Mark and providing positive updates to investors in October then to be followed by US regulatory approvals. OSL recently received the CE Mark to help push the share price higher this fortnight. LBT Innovations (LBT) is up 24% over the fortnight. LBT are the only US FDA-cleared AI technology for automated imaging, analysis and interpretations of culture plates following incubation. LBT have announced the first sale of APAS Independence instrument into Colonge, Germany along with other positive conference presentations over the last few weeks. and Sigma Health (SIG) are up +23% this fortnight. That rounds out the top performers for the last two weeks from the Health Care space and we’ll come to you next week with the latest leading companies leading the market higher.


Arrow Securities Group
 
Copyright © Arrow Securities Group Pty Ltd 2018
 
ABN  30 165 731 144   AFSL 448218